PROTECT Trial: Patient Related OuTcomes with Endeavor versus Cypher stenting Trial.

Trial Profile

PROTECT Trial: Patient Related OuTcomes with Endeavor versus Cypher stenting Trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Aug 2016

At a glance

  • Drugs Zotarolimus (Primary) ; Aspirin; Clopidogrel; Sirolimus
  • Indications Coronary artery disease; Coronary artery restenosis; Ischaemic heart disorders
  • Focus Therapeutic Use
  • Acronyms PROTECT
  • Sponsors Medtronic
  • Most Recent Events

    • 29 Mar 2016 Pooled secondary analysis of 2 trials - DAPT (n=11648) and PROTECT (n=8136) published in the JAMA: the Journal of the American Medical Association.
    • 09 Nov 2014 Planned End Date changed from 1 Jun 2014 to 1 Jul 2014, as reported by ClinicalTrials.gov record.
    • 05 Jun 2014 Planned End Date changed from 1 May 2014 to 1 Jun 2014 as reported by ClinicalTrials.gov record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top